The subcellular distribution and characteristics of trihydroxycoprostanoyl-CoA synthetase were studied in rat liver and were compared with those of palmitoyl-CoA synthetase and choloyl-CoA synthetase. Trihydroxycoprostanoyl-CoA synthetase and choloyl-CoA synthetase were localized almost completely in the endoplasmic reticulum. A quantitatively insignificant part of trihydroxycoprostanoyl-CoA synthetase was perhaps present in mitochondria. Peroxisomes, which convert trihydroxycoprostanoyl-CoA into choloyl-CoA, were devoid of trihydroxycoprostanoyl-CoA synthetase. As already known, palmitoyl-CoA synthetase was distributed among mitochondria, peroxisomes and endoplasmic reticulum. Substrate-and cofactor-(ATP, CoASH) dependence of the three synthesis activities were also studied. Cholic acid and trihydroxycoprostanic acid did not inhibit palmitoyl-CoA synthetase; palmitate inhibited the other synthetases non-competitively. Likewise, cholic acid inhibited trihydroxycoprostanic acid activation noncompetitively and vice versa. The pH curves of the synthetases did not coincide. Triton X-100 affected the activity of each of the synthetases differently. Trihydroxycoprostanoyl-CoA synthetase was less sensitive towards inhibition by pyrophosphate than choloyl-CoA synthetase. The synthetases could not be solubilized from microsomal membranes by treatment with 1 M-NaCl, but could be solubilized with Triton X-100 or Triton X-100 plus NaCl. The detergent-solubilized trihydroxycoprostanoyl-CoA synthetase could be separated from the solubilized choloyl-CoA synthetase and palmitoyl-CoA synthetase by affinity chromatography on Sepharose to which trihydroxycoprostanic acid was bound. Choloyl-CoA synthetase and trihydroxycoprostanoyl-CoA synthetase could not be detected in homogenates from kidney or intestinal mucosa. The results indicate that long-chain fatty acids, cholic acid and trihydroxycoprostanic acid are activated by three separate enzymes.
INTRODUCTION
In the liver, cholesterol is converted into di-and trihydroxycoprostanic acid via a series of enzymic steps that involve reduction of the double bond, hydroxylations of the steroid nucleus and oxidation of one of the terminal methyl groups of the aliphatic side chain. The enzymes that catalyse these reactions are distributed among the mitochondria, endoplasmic reticulum and cytosol [1] . Di-and tri-hydroxycoprostanic acid are then activated to their CoA esters, whose acyl side chains are subsequently shortened via fl-oxidation in peroxisomes, resulting in the formation of propionyl-CoA and of chenodeoxycholoyl-CoA and choloyl-CoA respectively [2] . These latter CoA-esters serve as substrates for the conjugation reactions with taurine or glycine. Conjugating activity is found in endoplasmic reticulum as well as in peroxisomes [3] .
The activation of di-and tri-hydroxycoprostanic acid has never been studied in detail, and it is not known by which enzyme the reaction is catalysed. Numerous compounds that contain an aliphatic chain with a terminal carboxy group are activated to CoA esters before they are further metabolized via f-oxidation, esterification or conjugation with amino acids. These compounds include short-, medium-, long-and very-long-chain fatty acids, dicarboxylic fatty acids, prostaglandins, retinoic acid [4] , xenobiotics with a carboxy side chain [5] , di-and trihydroxycoprostanic acid and C24 bile acids, such as chenodeoxycholic and cholic acid.
Short-and medium-chain fatty acids are activated mainly in the mitochondrial matrix [6] [7] [8] . Long-chain acyl-CoA synthetase activity is found in the mitochondrial outer membrane, the peroxisomal membrane and the endoplasmic reticulum [9] [10] [11] . The enzymes in the three organelles are of similar molecular mass and amino acid composition, show immunological crossreactivity and have the same kinetic characteristics, indicating that the activities reside in identical, or closely related, proteins [12] [13] [14] . It is not clear to what extent very-long-chain fatty acids can be activated by longchain acyl-CoA synthetase. Evidence is emerging that a separate specific enzyme exists, at least in liver peroxisomes [15] [16] [17] and in microsomes (microsomal fractions) from liver [15, 17] , brain [18, 19] and platelets [20] , and that very-long-chain acyl-CoA synthetase activity may be absent from mitochondria [15, 17] . Prostaglandins [21] , dicarboxylic fatty acids [22] and the C24 bile acids [23] are activated solely in the endoplasmic reticulum. The enzymes that catalyse the activation of dicarboxylic fatty acids and of C24 bile acids appear to be different from the long-chain fatty acyl-CoA synthetase [22, 24] . In the present work we studied the subcellular distribution of trihydroxycoprostanoyl-CoA synthetase and compared the characteristics of the enzyme with those of long-chain fatty acyl-CoA synthetase and choloyl-CoA synthetase. The latter enzyme is responsible for the activation of C24 bile acids re-entering the liver via enterohepatic recirculation and is considered to catalyse the rate-limiting reaction in the conjugation of these recirculating bile acids [25, 26] . Our results show that, like choloyl-CoA synthetase, trihydroxycoprostanoyl-CoA synthetase is present predominantly in the endoplasmic reticulum. Its properties differ in several respects from those of long-chain acyl-CoA synthetase and choloylCoA synthetase, and the three synthetases can be separated from each other by affinity chromatography, indicating the occurrence of three separate enzymes. The further characterization and identification of acyl-CoA synthetases is not of purely academic interest, since a deficiency of a peroxisomal very-long-chain acyl-CoA synthetase has recently been proposed as the basic defect in X-chromosome-linked adrenoleucodystrophy [16, 17, 27, 28] .
EXPERIMENTAL

Materials
CoA and dithiothreitol were from P-L Biochemicals, Milwaukee, WI, U.S.A. ATP and Triton X-100 were obtained from Boehringer-Mannheim, Mannheim, Germany. Bovine serum albumin (fraction V, powder) was purchased from Sigma Chemical Co., St. Louis, MO, U.S.A. The albumin was defatted by the method of Chen [29] , dialysed in the cold for 48 h against water, then freeze-dried. [1_-4C]Palmitate (sp. radioactivity 58 mCi/mmol) was obtained from Amersham International, Amersham, Bucks., U.K. [2,4-3H]Cholic acid (sp. radioactivity 25 Ci/mmol) was from New England Nuclear, Boston, MA, U.S.A. Trihydroxycoprostanic acid was purified from alligator bile [30] . Radiolabelled [3,7,1 2-3H]trihydroxycoprostanic acid (sp. radioactivity 26.3 mCi/mmol) was prepared as described previously [31] . Epoxy-activated Sepharose 6B was from Pharmacia, Uppsala, Sweden.
Animals
Male Wistar rats weighing 120-150 g were used. They were maintained on a standard laboratory chow diet.
Preparation of subceliular fractions
Liver homogenates (20 %, w/v) were prepared in 0.25 M-sucrose containing 0.1 % (v/v) ethanol and 5 mMdithiothreitol, and fractionated into nuclear (N), heavy mitochondrial (M), light mitochondrial (L), microsomal (P) and soluble (S) fractions as described by de Duve et al. [32] . The L-fraction was subfractionated in a selfgenerating Percoll gradient [10] .
Determination of marker enzymes and protein
Marker enzymes [glutamate dehydrogenase (mitochondrial matrix); catalase (peroxisomal matrix); urate oxidase (peroxisomal core) and glucose-6-phosphatase (endoplasmic reticulum)] were determined as described previously [33] . Protein was measured by the method of Peterson [34] . Assay of palmitoyl-CoA synthetase, choloyl-CoA synthetase and trihydroxycoprostanoyl-CoA synthetase Trihydroxycoprostanoyl-CoA synthetase was measured as described recently [31] . The [24] and by Roughan & Slack [35] respectively. The activation of trihydroxycoprostanic acid and cholic acid was linear with time for up to 4 min in whole liver homogenates and for up to 20 min in subcellular fractions. The chosen reaction times were 3 min (homogenates) or 10 min (subcellular fractions). Palmitoyl-CoA synthetase activity was linear with time for 5 min in whole homogenates and in subcellular fractions. The chosen reaction time was 3 min.
Solubilization of the synthetase activities
Isolated microsomes were treated successively with 1 MNaCl, 1 % (w/v) Triton X-100 and 1 % (w/v) Triton X-100 plus 1 M-NaCl. The salt and detergent solutions were buffered with 10 mM-Mops, pH 7.2, and contained 1 mM-dithiothreitol, 0.5 mM-p-toluenesulphonyl fluoride and 5 % (v/v) dimethyl sulphoxide. The initial microsomal protein concentration was approx. 20 mg/ml. Contact time with salt or detergent was 30 min at 4 'C. After each treatment, the proteins that were not released were sedimented by centrifugation at 100 000 g for 40 min. The supernatants were saved for protein and enzyme determinations and the pellets subjected to the subsequent treatment.
Affinity chromatography The 3-hydroxy group of trihydroxycoprostanic acid was linked to Sepharose by means of a Lewis acidcatalysed coupling of 3a-hydroxy-7a,12a-diformyloxycoprostanic acid to epoxy-activated Sepharose, followed by hydrolysis of the protective formyl ester groups. The 7a,12a-diformyl derivative of trihydroxycoprostanic acid was prepared by formylation of trihydroxycoprostanic acid, followed by partial deformylation in NH3-saturated methanol as described by Tserng & Klein [36] . A trace amount of [3,7,1 2-3H]trihydroxycoprostanic acid was added at the start of the formylation reaction. A portion (2 g) of freeze-dried epoxy-activated Sepharose 6B was allowed to swell in water and washed with, successively, water, anhydrous ethanol, acetone and dry methylene chloride. The washed gel was resuspended in 8 ml of dry methylene chloride containing 60 mg of the diformylated ligand. The slurry was swirled at room temperature, and 0.5 ml of boron fluoride ethyl ether was added in five equal portions at intervals of 15 min. After another 30 min, the gel was washed with, successively, methylene chloride, acetone, water, 0.1 M-borate buffer, pH 8, 0.1 M-acetate buffer, pH 4, and water. Excess reactive groups on the Sepharose were blocked with 1 Methanolamine overnight at 40 'C. The protective formyl ester groups of the diformylated ligand were hydrolysed in this step. After having been washed with water, the derivatized gel was stored at 4 'C in water containing 0.02 % (w/v) NaN3. Approx. 9 ltmol of trihydroxycoprostanic acid were coupled/g of Sepharose, as estimated from radioactivity measurements on portions of the gel.
Isolated microsomes were solubilized with Triton X-100 plus NaCl as described above, except that the initial protein concentration was approx. 4 mg/ml. The solubilized proteins were dialysed overnight at 4 'C against 10 mM-Mops, pH 7.2, containing 5 mM-,/-mercaptoethanol and 1 % (w/v) Triton X-100 to remove most of the salt. ATP and MgCl2 were added to the dialysed protein solution to final concentrations of 5 mm and 3 mM respectively. A 2 ml portion of the solution, containing approx. 4 mg of protein, was loaded on a trihydroxycoprostanic acid-Sepharose column (bed volume 3.1 ml), previously equilibrated with 10 mMMops, pH 7.2, containing 5 mM-/J-mercaptoethanol and 0.1 % (w/v) Triton X-100. The column was washed with 3 column vol. of the equilibration buffer containing 5 mM-ATP and 3 mM-MgCl2 and eluted successively with 20 mM-potassium phosphate buffer, pH 7.2, 20 mMacetate buffer, pH 4, and 20 mM-acetate buffer containing 0.5 M-NaCl, as indicated in the legend to Fig. 8 Fig. 1 . In agreement with its known localization in mitochondria, peroxisomes and endoplasmic reticulum, palmitoyl-CoA synthetase activity was distributed among all particulate fractions. Like choloyl-CoA synthetase, trihydroxycoprostanoyl-CoA synthetase closely followed the distribution of glucose-6-phosphatase, indicating that it is localized predominantly in the endoplasmic reticulum. Since different amounts of acyl-CoA hydrolase activity in the various subcellular fractions might affect the apparent subcellular distribution of the synthetase activities, we also measured the activation of cholic acid and of trihydroxycoprostanic acid in the subcellular fractions in the presence of albumin at a substrate/albumin molar ratio of 1:1. The presence of albumin does not inhibit trihydroxycoprostanoyl-CoA synthetase or choloyl-CoA synthetase (see below), but partially suppresses the hydrolase activities [21, 31] . The subcellular distributions of the synthetases were identical when measured in the presence or absence of albumin (results not shown).
In a subsequent experiment, the light mitochondrial fraction (L-fraction), prepared by differential centrifugation, was subfractionated by isopycnic centrifugation in an iso-osmotic self-generating Percoll gradient. As estimated from the activities of the marker enzymes, this L-fraction contained 250% of the mitochondria, 3000
(catalase)-54 Qo (urate oxidase) of the peroxisomes and only 70 of the endoplasmic reticulum. The discrepancy between the percentages of catalase and urate oxidase present in the L-fraction is due to the fact that part of the catalase leaks from the peroxisomes during homogenization of the liver. Fig. 2 shows the gradient distribution of marker enzymes and of trihydroxycoprostanoyl-CoA synthetase and choloyl-CoA synthetase. Choloyl-CoA synthetase and especially trihydroxycoprostanoyl-CoA synthetase displayed a bimodal distribution: the main part of the activity was present in the gradient fractions containing the endoplasmic reticulum fragments, but activity was also found in the fractions enriched in mitochondria. Peroxisomes clearly did not show activity. In the interpretation of the results it should be borne in mind that, on a relative basis, endoplasmic reticulum was 3-4 times less abundant than mitochondria in the L-fraction loaded on the gradient. Assuming that all synthetase activity present in the peak mitochondrial and microsomal (endoplasmic reticulum) fractions, was localized exclusively in mitochondria and endoplasmic reticulum respectively, we could calculate from the activities of the respective marker enzymes in these peak fractions that mitochondria would be responsible for at most 6.5 and 2 % of the total cellular activity of trihydroxycoprostanoyl-CoA synthetase and choloylCoA synthetase respectively. Synthetase activities were also measured in the presence of optimum concentrations ofTriton X-100 (see below). The presence of the detergent did not affect the subcellular distribution pattern of the synthetases. Substrate-and cofactor-dependence
The subsequent experiments were carried out with microsomal fractions prepared by differential centrifugation. Fig. 3 shows the substrate-dependence of the synthetases measured with palmitic, cholic and trihydroxycoprostanic acid. Palmitoyl-CoA synthetase (Fig. 3a) followed Michaelis-Menten kinetics. The ap- 
4LA iL per mg of protein, calculated from the double-reciprocal plot (Fig. 3a, inset) , are of the order of magnitude of previously published values [36, 37] . With cholic acid as the substrate (Fig. 3b) 16, 38 and 13 ,tM for palmitoyl-CoA synthetase, choloylCoA synthetase and trihydroxycoprostanoyl-CoA synthetase respectively (n = 2). The values for ATP were 1.5, 3.5 and 4 mm respectively (n = 2). Pyrophosphate, a product of the reaction, inhibited all three synthetases. There was a clear distinction between the inhibition curves for palmitoyl-CoA synthetase and choloyl-CoA synthetase on the one hand and for trihydroxycoprostanoyl-CoA synthetase on the other (Fig.  4) , suggesting that choloyl-CoA synthetase and trihydroxycoprostanoyl-CoA synthetase may be distinct enzymes.
Substrate-competition experiments
Cholic acid and trihydroxycoprostanic acid used over the concentration range 0-200 /gM did not inhibit palmitoyl-CoA synthetase (results not shown). As already reported by our laboratory [31] , palmitate potently inhibited trihydroxycoprostanic acid activation in a noncompetitive way. Likewise, cholic acid activation was potently and non-competitively inhibited by palmitate (approx. 50 % inhibition at 10 ,sM-palmitate; results not shown). We also studied the effect of cholic acid on trihydroxycoprostanic acid activation and vice versa. Each substrate inhibited the activation of the other substrate, trihydroxycoprostanic acid being the more potent inhibitor (Fig. 5) . The pattern of the curves as well as the double-reciprocal plots agree with the occurrence of non-competitive inhibition. We emphasize, however, that because of the complex nature of the kinetics observed in Fig. 3 , we do not want to rely too heavily on this interpretation of the results. pH-dependence pH-dependence was studied over the pH range 6-9. Trihydroxycoprostanoyl-CoA synthetase showed an optimum at pH 7.5, whereas the two other synthetases reached their highest activities at pH 9 (Fig. 6) . These results again suggest that trihydroxycoprostanoyl-CoA synthetase and choloyl-CoA synthetase may be separate enzymes.
Effect of albumin and Triton X-100
Albumin, added to the standard assay mixtures, stimulated all three synthetase activities. The highest activities were reached at a substrate/albumin molar ratio of 2:1 for palmitoyl-CoA synthetase and at a molar ratio of 1:1 for choloyl-CoA synthetase and trihydroxycoprostanoyl-CoA synthetase. The respective percentages of stimulation were 105, 102 and 80. The stimulatory effect of albumin remains unexplained, but (part of) the explanation might be a suppression of acylCoA hydrolase activities (see above). Triton X-100, added at low concentrations to the standard assay mixtures, also stimulated the synthetase activities (Fig.  7) . The optimum stimulatory concentration of detergent differed for each of the three activities. At a high concentration of 0.5 % (w/v), the detergent remained stimulatory for palmitoyl-CoA synthetase, it inhibited slightly trihydroxycoprostanoyl-CoA synthetase and inhibited markedly choloyl-CoA synthetase. Since Triton X-100 was used above its critical micelle concentration, the detergent may have formed mixed micelles with each of the substrates. It is therefore difficult to know whether the differential effect of the detergent on the different enzyme activities was due to a direct effect on Microsomal proteins were solubilized with Triton X-100 plus NaCl and subsequently dialysed to remove the salt. A portion of the dialysed proteins was loaded on an affinity column, which consisted of Sepharose to which trihydroxycoprostanic acid had been bound (Fig. 8) Microsomes were treated successively with 1 M-NaCl, 1 % (w/v) Triton X-100 and 1 % (w/v) Triton X-100 plus 1 M-NaCl as described in the Experimental section. After each treatment the released protein and synthetase activities were measured. The Triton X-100 concentration in the assays was 0.2% (w/v). The NaCl concentrations in the assays were not adjusted, since NaCl did not affect the synthetase activities. Results are expressed as percentages of the total recovered activity or amount and are means for two experiments. Essentially the same release pattern was observed when the synthetase activities were measured in the presence of 0.05% (w/v) Triton X-100 (results not shown). shown that trihydroxycoprostanoyl-CoA synthetase was better retained on the column in the presence of this nucleotide. The washing removed more than 990 of the recovered protein and of the recovered palmitoyl-CoA synthetase from the column, but also approximately half of the recovered trihydroxycoprostanoyl-CoA synthetase and choloyl-CoA synthetase. Elution of the column with buffer in the absence of ATP resulted in a substantial peak of trihydroxycoprostanoyl-CoA synthetase (Fig. 8,  fraction 4) . Very little choloyl-CoA synthetase activity was eluted with this peak, clearly showing that trihydroxycoprostanoyl-CoA synthetase and choloyl-CoA synthetase are separate enzymes. Subsequent elution at acidic pH resulted in the appearance of smaller peaks of trihydroxycoprostanoyl-CoA synthetase or choloyl-CoA synthetase activity. It is not surprising that choloyl-CoA synthetase was also partly retained on the column, since trihydroxycoprostanic acid is a potent inhibitor of choloyl-CoA synthetase (Fig. 5b) . The specific acitivity of trihydroxycoprostanoyl-CoA synthetase in fraction 4 of the eluate was 113 munits/mg of protein, a 124-fold purification in comparison with the starting material loaded on the column. Tissue distribution Synthetase activities were also measured in homogenates from kidney and intestinal mucosa. PalmitoylCoA synthetase was found, but choloyl-CoA synthetase and trihydroxycoprostanoyl-CoA synthetase could not be detected. Polokoff & Bell [24] also failed to detect choloyl-CoA synthetase activity in extrahepatic tissues. Palmitoyl-CoA synthetase amounted to approx. 0.5 and 1 ,tmol/min per g of tissue in kidney and intestinal mucosa respectively. This is 20 and 10 times less respectively than the activity found per g of liver.
